APLIF (Appili Therapeutics) Short-Term Debt : $7.09 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Short-Term Debt?

Appili Therapeutics's Short-Term Debt for the quarter that ended in Sep. 2024 was $7.09 Mil.

Appili Therapeutics's quarterly Short-Term Debt increased from Mar. 2024 ($5.40 Mil) to Jun. 2024 ($6.71 Mil) and increased from Jun. 2024 ($6.71 Mil) to Sep. 2024 ($7.09 Mil).

Appili Therapeutics's annual Short-Term Debt increased from Mar. 2022 ($0.08 Mil) to Mar. 2023 ($0.08 Mil) and increased from Mar. 2023 ($0.08 Mil) to Mar. 2024 ($5.40 Mil).

Appili Therapeutics Short-Term Debt Historical Data

The historical data trend for Appili Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Short-Term Debt Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

0.04

0.07

0.08

5.40

Appili Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															0.26	0.31	5.40	6.71	7.09

Appili Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Appili Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.